October 24 Webinar Agenda

  • October 24, 2020
Invited Speakers
Dominick J. Angiolillo, MD, PhD

University of Florida College of Medicine
Jacksonville, Florida

Subhash Banerjee, MD

VA North Texas Health Care System
Dallas, Texas

C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center

Neal Kleiman, MD

Houston Methodist DeBakey Heart and Vascular Center
Houston, Texas

Konstantinos Koskinas, MD

Bern University Hospital
Bern, Switzerland

Carlos Mena, MD

Yale University
Branford, CT

Duane Pinto, MD

Beth Israel Deaconess Medical Center
Boston , MA

Adhir Shroff, MD

University of Illinois at Chicago
Jesse Brown Medical Center
Chicago, IL

Rajiv Tayal, MD

St. Michael's Medical Center
Warren, NJ

Michael A. Vavarunkis, MD

Johns Hopkins University School of Medicine
Baltimore, MD

8:00 AM
Welcome and Introduction

Ron Waksman, MD

ACCESS TO CLOSURE

8:05 AM
Why Access Matters & Closure Devices

Adhir Shroff, MD

8:35 AM
Access & Closure Complications & Data and Outcomes

Duane Pinto, MD

9:05 AM
Proglide Components & Deployment & Large Bore Closure

Raj Tayal, MD

9:35 AM
Tips & Techniques

Carlos Mena, MD

NEW EVIDENCE OF LIPID LOWERING IN ACS PATIENTS

10:05 AM
EVOPACS Data: ESC Guidelines - Recommended Lower LDL Goals: How Low Should We Go?

Konstantinos Koskinas, MD

10:25 AM
EVACS DATA: ACC/AHA Guidelines - Timing of Treatment for Fastest Patient LDL Reduction

Michael A. Vavarunkis, MD

10:45 AM
Debate, Questions and Answers

Konstantinos Koskinas, MD | Michael A. Vavarunkis, MD

TICAGRELOR NEW STUDIES, NEW LABELING AND NEW GUIDELINES

11:05 AM
REVIEW OF NEW ESC GUIDELINES: SHOULD WE CHANGE OUR PRACTICE?

C. Michael Gibson, MD​

11:20 AM
Deep Dive into the ISAR REACT 5 Study Results

Subhash Banerjee, MD

11:35 AM
Ticagrelor: New Studies, New Labeling and Update on THEMIS and Other Studies

Dominick Angilillo, MD, PhD

11:55 AM
What is the Data to Support Preloading of Ticagrelor?

Neal Kleiman, MD

12:10 PM
Final Remarks and Adjourn

Ron Waksman, MD

MedStar Washington Hospital Center would like to thank

for supporting the CRTvirtual Course

Amgen and AstraZeneca 

for their support through an educational grant